Positive association of AKT1 haplotype to Japanese methamphetamine use disorder

International Journal of Neuropsychopharmacology

Volumn 9, Issue 1, 2006, Pages 77-81

  Ikeda, Masashi ^a,b   Iwata, Nakao ^a,c   Suzuki, Tatsuyo ^a   Kitajima, Tsuyoshi ^a   Yamanouchi, Yoshio ^a   Kinoshiya, Yoko ^a   Sekine, Yoshimoto ^c,d   Iyo, Masaomi ^c,e   Harano, Mutsuo ^c,f   Komiyama, Tokutaro ^c,g   Yamada, Mitsuhiko ^c,g   Sora, Ichiro ^c,h   Ujike, Hiroshi ^c   Inada, Toshiya ^b,c   Ozaki, Norio ^b,c  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e CHIBA UNIVERSITY   (Japan)

^f KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^h TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopamine dependent behaviours; Linkage disequilibrium; Substance related disorders

Indexed keywords

METHAMPHETAMINE; PROTEIN KINASE B;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG ABUSE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; UNITED STATES;

ADULT; AMPHETAMINE-RELATED DISORDERS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; JAPAN; MALE; METHAMPHETAMINE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 30344446312     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145705005481     Document Type: Article

References (12)

1. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG (2004). Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences USA 101, 5099-5104.
2. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA (2004). Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nature Genetics 36, 131-137.
3. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Inada T, Ozaki N (2004). Association of AKT1 with schizophrenia confirmed in a Japanese population. Biological Psychiatry 56, 698-700.
4. Jang KL, Livesley WJ, Vernon PA (1997). Gender-specific etiological differences in alcohol and drug problems: a behavioural genetic analysis. Addiction 92, 1265-1276.
5. Lin SK, Chen CK, Ball D, Liu HC, Loh EW (2003). Gender-specific contribution of the GABA(A) subunit genes on 5q33 in methamphetamine use disorder. Pharmacogenomics Journal 3, 349-355.
6. Nishiyama T, Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada K, Sora I, Ujike H, Inada T, Ozaki N (2005). Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder. Pharmacogenomics Journal 5, 89-95.
7. Ohtsuki T, Inada T, Arinami T (2004). Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Molecular Psychiatry 9, 981-983.
8. Spanagel R, Weiss F (1999). The dopamine hypothesis of reward: past and current status. Trends in Neurosciences 22, 521-527.
9. Suzuki T, Iwata N, Kitamura Y, Kitajima T, Yamanouchi Y, Ikeda M, Nishiyama T, Kamatani N, Ozaki N (2003). Association of a haplotype in the serotonin 5-HT4 receptor gene (HTR4) with Japanese schizophrenia. American Journal of Medical Genetics 121B, 7-13.
10. Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, Meyer JM, Toomey R, Faraone SV, Eaves L (1996). Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. American Journal of Medical Genetics 67, 473-477.
11. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L (1998). Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Archives of General Psychiatry 55, 967-972.
12. Ujike H, Harano M, Inada T, Yamada M, Komiyama T, Sekine Y, Sora I, Iyo M, Katsu T, Nomura A, Nakata K, Ozaki N (2003). Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics Journal 3, 242-247.